Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Implications for Clinical Trial Design. Reply.

The Journal of Urology ◽

10.1097/ju.0000000000002238 ◽

2021 ◽

Author(s):

Patrick J. Hensley ◽

Ashish M. Kamat

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Trial Design ◽

Clinical Trial Design ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Nonmuscle Invasive Bladder Cancer

Get full-text (via PubEx)

Contemporary Outcomes of Patients With Nonmuscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin: Implications for Clinical Trial Design. Letter.

The Journal of Urology ◽

10.1097/ju.0000000000002237 ◽

2021 ◽

Author(s):

Francesco Montorsi ◽

Marco Moschini ◽

Andrea Necchi ◽

Federico Deho ◽

Giorgio Gandaglia ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Trial Design ◽

Clinical Trial Design ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Nonmuscle Invasive Bladder Cancer

Get full-text (via PubEx)

Clinical Trial Design for the Development of New Therapies for Nonmuscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop

Urology ◽

10.1016/j.urology.2013.10.030 ◽

2014 ◽

Vol 83 (2) ◽

pp. 262-265 ◽

Cited By ~ 37

Author(s):

Jonathan P. Jarow ◽

Seth P. Lerner ◽

Paul G. Kluetz ◽

Ke Liu ◽

Rajeshwari Sridhara ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Drug Administration ◽

Trial Design ◽

Food And Drug Administration ◽

Clinical Trial Design ◽

Invasive Bladder Cancer ◽

New Therapies ◽

American Urological Association ◽

Nonmuscle Invasive Bladder Cancer

Get full-text (via PubEx)

Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design

European Urology ◽

10.1016/j.eururo.2016.02.031 ◽

2016 ◽

Vol 70 (5) ◽

pp. 778-785 ◽

Cited By ~ 18

Author(s):

Chinedu O. Mmeje ◽

Charles C. Guo ◽

Jay B. Shah ◽

Neema Navai ◽

H. Barton Grossman ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Trial Design ◽

Clinical Trial Design ◽

Bacillus Calmette Guerin

Get full-text (via PubEx)

International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer

European Urology ◽

10.1016/j.eururo.2021.12.005 ◽

2021 ◽

Author(s):

Mathieu Roumiguié ◽

Ashish M. Kamat ◽

Trinity J. Bivalacqua ◽

Seth P. Lerner ◽

Wassim Kassouf ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Trial Design ◽

Consensus Statement ◽

Clinical Trial Design ◽

Bacillus Calmette Guerin ◽

Group Consensus ◽

Muscle Invasive Bladder Cancer ◽

Cancer Group ◽

Muscle Invasive

Get full-text (via PubEx)

Re: Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design

The Journal of Urology ◽

10.1016/j.juro.2017.04.093 ◽

2017 ◽

Vol 198 (2) ◽

pp. 255-255

Author(s):

Sam S. Chang

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Trial Design ◽

Clinical Trial Design ◽

Bacillus Calmette Guerin

Get full-text (via PubEx)

Re: Jarow JP et al.: Clinical Trial Design For the Development of New Therapies for Non–muscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop (Urology 2014;83:262-265)

Urology ◽

10.1016/j.urology.2014.03.034 ◽

2014 ◽

Vol 84 (2) ◽

pp. 494-495 ◽

Cited By ~ 2

Author(s):

John Amrhein ◽

Ashish M. Kamat ◽

Alvaro Morales

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Drug Administration ◽

Trial Design ◽

Food And Drug Administration ◽

Clinical Trial Design ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

American Urological Association

Get full-text (via PubEx)

Contemporary Outcomes of Patients with Non-Muscle Invasive Bladder Cancer Treated with BCG Therapy: Implications for Clinical Trial Design

The Journal of Urology ◽

10.1097/ju.0000000000001633 ◽

2021 ◽

Author(s):

Justin T. Matulay ◽

Roger Li ◽

Patrick J. Hensley ◽

Nathan A. Brooks ◽

Vikram M. Narayan ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Trial Design ◽

Clinical Trial Design ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Bcg Therapy ◽

Muscle Invasive

Get full-text (via PubEx)

Faculty Opinions recommendation of Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3246962.2931060 ◽

2010 ◽

Author(s):

Juan Palou Redorta ◽

Guillermo Urdaneta

Keyword(s):

Bladder Cancer ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Scoring Model ◽

Bladder Cancer Recurrence ◽

Nonmuscle Invasive Bladder Cancer

Get full-text (via PubEx)

Bacteria-Derived Alternatives to Live Mycobacterium bovis Bacillus Calmette–Guerin for Nonmuscle Invasive Bladder Cancer Treatment

Microbial Infections and Cancer Therapy ◽

10.1201/9781351041904-4 ◽

2019 ◽

pp. 123-188

Author(s):

Esther Julián ◽

Estela Noguera-Ortega

Keyword(s):

Bladder Cancer ◽

Cancer Treatment ◽

Mycobacterium Bovis ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Nonmuscle Invasive Bladder Cancer

Get full-text (via PubEx)

Comparable effect with minimal morbidity of low-dose Tokyo 172 strain compared with regular dose Connaught strain as an intravesical bacillus Calmette-Guérin prophylaxis in nonmuscle invasive bladder cancer: Results of a randomized prospective comparison

Urology Annals ◽

10.4103/0974-7796.106873 ◽

2013 ◽

Vol 5 (1) ◽

pp. 7 ◽

Cited By ~ 8

Author(s):

Teruo Inamoto ◽

Takanobu Ubai ◽

Takeshi Nishida ◽

Yutaka Fujisue ◽

Yoji Katsuoka ◽

...

Keyword(s):

Bladder Cancer ◽

Low Dose ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Minimal Morbidity ◽

Prospective Comparison ◽

Comparable Effect ◽

Nonmuscle Invasive Bladder Cancer

Get full-text (via PubEx)